BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for ...

Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and ...

Inhibrx Biosciences’ antibody ozekibart has notched a key phase 2 win in a rare bone cancer that currently has no approved ...

The position statement from cancer and bone societies updates recommendations from 2017 for managing bone loss and fracture ...

Kids with a rare bone cancer called Ewing sarcoma might live longer if prescribed pazopanib, a drug that blocks blood supply ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...